Stock Market
Veracyte Stock Crashes Following Growth Reset For Decipher Test
Veracyte shares plunged nearly 60 percent on Thursday after the company adjusted growth projections for its Decipher prostate cancer tissue test.
Friday, 6 November 2026
Trending Now
Early Polar Vortex Disruption Sparks Uncertainty Over UK WeatherGate Reports 104% Cold Reserve Coverage Amid Snapshot Date ConcernsTrump Signs Proclamation Protecting Oval Office DesignPope Leo XIV begins Latin America trip after lung surgeryTurkiye’s Parliament Approves the Mecca Defence AgreementThe complex engineering behind single crystal turbine engine partsCore Scientific to End Bitcoin Mining by Year-End for AI ShiftCrude oil prices rise as Middle East war outlook is reassessedEarly Polar Vortex Disruption Sparks Uncertainty Over UK WeatherGate Reports 104% Cold Reserve Coverage Amid Snapshot Date ConcernsTrump Signs Proclamation Protecting Oval Office DesignPope Leo XIV begins Latin America trip after lung surgeryTurkiye’s Parliament Approves the Mecca Defence AgreementThe complex engineering behind single crystal turbine engine partsCore Scientific to End Bitcoin Mining by Year-End for AI ShiftCrude oil prices rise as Middle East war outlook is reassessed